New eye drug shows promise for dry AMD in early trial
NCT ID NCT07160179
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This study tests a new medicine called ABBV-6628 for people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes vision loss. About 66 adults aged 50 and older will receive injections into the eye to see if the drug is safe and how it works. The trial compares ABBV-6628 to an approved treatment (SYFOVRE) and involves regular checkups over about 22 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Retina Consultants - The Woodlands /ID# 262138
RECRUITINGThe Woodlands, Texas, 77384, United States
-
Retina Foundation of the Southwest /ID# 262479
RECRUITINGDallas, Texas, 75231, United States
Contact Phone: •••-•••-••••
-
Retina Partners Midwest, P.C. /ID# 262172
RECRUITINGCarmel, Indiana, 46032, United States
-
Retina Research Institute of Texas /ID# 262141
RECRUITINGAbilene, Texas, 79606-1224, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.